- Bahrain & Saudi Arabia
- China & Hong Kong
- Czech Republic
- South Africa
- Sri Lanka
- United Kingdom
- Our Approach to Sustainability
- Message from President & CEO
- Sustainability Report
- Policy and Our Action
- Our Initial Response to the
- KWE CO2 Calculator
- Social Impacts in the Supply Chain
- Occupational Safety and Health
- Social Contributions
- Data Security
- Corporate Governance
- Risk Management
During the global emergence of COVID-19, scientists, doctors, and world leaders worked against time to understand and respond to the exponentially growing health crisis.
Among these multilateral efforts, decisions by many countries to close international borders proved to be a double-edged sword as many industries that enjoyed the readily available belly-hold capacity on passenger flights were critically impacted by their reductions.
Our client, an American supplier of medical devices, faced that very challenge as they supplied testing reagents to the European Union and the United Kingdom.
With a lead-time requirement of 2 days and a near-total absence of direct service routes, KWE's healthcare experts were tasked to develop a comprehensive solution in the face of uncertainty.
With pre-existing knowledge of our client's shipment history and handling requisites, our dedicated project team leveraged existing carrier partnerships and compiled trade-lane analyses to provide alternative routings without compromising lead-time performance.
In efforts to mitigate or circumvent market volatility, a control tower was also established to manage day-to-day operations from cargo booking to last-mile fulfillment.
Among the logistics experts selected for this challenge, KWE stands as the only provider able to consistently meet our client's short transit requirement, expediting delivery to Amsterdam and summarily transported to the United Kingdom, where the reagents were utilized in the government's testing and screening campaigns.
Another story might interest you:
How can we help you go faster?